Trials
Search / Trial NCT06436118

Evaluation of the Use of the RELAX® Glasses on the Anxiety of Patients Undergoing Emergency Hand Surgery Under Locoregional Anesthesia

Launched by CENTRE HOSPITALIER DE VALENCIENNES · May 28, 2024

Trial Information

Current as of February 19, 2025

Completed

Keywords

Audiovisual Sedation Anxiety Hand Surgery Locoregional Anesthesia

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients treated for hand surgery under emergency locoregional anesthesia (Wounds, fractures and infections of the hand and wrist).
  • Over 15 years and 3 months of age on the day of inclusion.
  • Patient with written consent or additional parental consent in the case of minor patients.
  • Socially insured patient.
  • Patient willing to comply with all study procedures and duration.
  • Exclusion Criteria:
  • Medical history contraindicating RELAX glasses: claustrophobia.
  • Known and current alcohol and/or illicit drug abuse that may interfere with patient safety and/or compliance.
  • Any condition that would make the patient unfit for the study: current presence of cognitive impairment (MMS \<15), severe psychiatric disorders (bipolar disorder, psychotic disorders according to the DSM-V classification).
  • Pregnant or breastfeeding woman.
  • Patient under court protection.
  • Patient participating in another study.
  • Patient's refusal to use the headset.

About Centre Hospitalier De Valenciennes

The Centre Hospitalier de Valenciennes is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Valenciennes, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge scientific inquiry. With a multidisciplinary team of healthcare professionals and researchers, the Centre Hospitalier de Valenciennes aims to contribute to the development of new therapies and treatment strategies, enhancing the health outcomes of diverse patient populations. The institution adheres to rigorous ethical standards and regulatory guidelines, ensuring the highest quality and safety in its clinical research endeavors.

Locations

Valenciennes, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0